Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era
- 31 May 2004
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 28 (5) , 429-442
- https://doi.org/10.1016/j.leukres.2003.08.017
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemiaBlood, 2003
- Results of the Fludarabine and Cyclophosphamide Combination Regimen in Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabineLeukemia, 2000
- Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial TherapyBlood, 1998
- The induction of p53 and WAF1/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosineJournal of Molecular Medicine, 1996
- Cellular Pharmacology of Fludarabine Triphosphate in Chronic Lymphocytic Leukemia Cells During Fludarabine TherapyLeukemia & Lymphoma, 1993
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975
- Nucleosides of 2-FluoroadenineJournal of Medicinal Chemistry, 1969